Deltex Medical Group plc (LON:DEMG) will release the preliminary earnings for 2007 on Monday, April 7.
Headquartered in
The CardioQ is used to monitor the heart’s performance of critically ill patients and patients undergoing surgery. The product identifies and monitors problems early, allowing doctors to optimize the patient’s haemodynamic status.
The company is operated within three subsidiaries, Deltex Medical Limited, which is engage din the manufacture and marketing of medical devices, Deltex Medical Holdings Inc, marketing and selling medical devices in the